| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |